Masao Honda
About
Masao Honda is a scholar working on Hepatology, Epidemiology and Molecular Biology.
According to data from OpenAlex, Masao Honda has authored 259 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hepatology, 107 papers in Epidemiology and 84 papers in Molecular Biology. Recurrent topics in Masao Honda's work include Hepatitis C virus research (73 papers), Liver Disease Diagnosis and Treatment (68 papers) and Hepatitis B Virus Studies (53 papers). Masao Honda is often cited by papers focused on Hepatitis C virus research (73 papers), Liver Disease Diagnosis and Treatment (68 papers) and Hepatitis B Virus Studies (53 papers). Masao Honda collaborates with scholars based in Japan, United States and China. Masao Honda's co-authors include Shuichi Kaneko, Taro Yamashita, Shuichi Kaneko, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Toshinari Takamura, Kenichi Kobayashi, Kuniaki Arai and Stanley M. Lemon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
In The Last Decade
Masao Honda
240 papers receiving 9.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Masao Honda Japan | 51 | 3.9k | 3.8k | 3.7k | 1.8k | 1.8k | 259 | 10.0k | ||
| Hitoshi Yoshiji Japan | 50 | 3.7k 0.9× | 3.2k 0.8× | 3.3k 0.9× | 2.3k 1.3× | 2.2k 1.2× | 365 | 10.9k | ||
| Steven Dooley Germany | 53 | 4.5k 1.1× | 3.7k 1.0× | 3.0k 0.8× | 1.2k 0.6× | 1.7k 0.9× | 237 | 10.2k | ||
| Steven F. Bronk United States | 65 | 5.6k 1.4× | 2.4k 0.6× | 5.0k 1.3× | 2.0k 1.1× | 2.2k 1.2× | 101 | 12.1k | ||
| Tatsuya Yamashita Japan | 48 | 2.0k 0.5× | 3.8k 1.0× | 3.0k 0.8× | 829 0.5× | 1.8k 1.0× | 239 | 8.3k | ||
| Matías A. Ávila Spain | 58 | 4.9k 1.3× | 1.8k 0.5× | 2.4k 0.6× | 1.3k 0.7× | 1.5k 0.8× | 220 | 9.8k | ||
| Norifumi Kawada Japan | 58 | 3.3k 0.8× | 5.0k 1.3× | 5.3k 1.4× | 1.0k 0.6× | 938 0.5× | 371 | 11.3k | ||
| Claus Hellerbrand Germany | 66 | 5.7k 1.5× | 3.9k 1.0× | 5.3k 1.4× | 2.4k 1.3× | 2.0k 1.1× | 291 | 14.3k | ||
| Isao Sakaida Japan | 50 | 2.6k 0.7× | 3.8k 1.0× | 3.6k 1.0× | 934 0.5× | 1.5k 0.8× | 394 | 10.0k | ||
| Tatiana Kisseleva United States | 59 | 4.7k 1.2× | 5.7k 1.5× | 6.1k 1.6× | 1.3k 0.7× | 1.6k 0.9× | 124 | 14.5k | ||
| Christoph H. Österreicher Austria | 26 | 2.0k 0.5× | 2.7k 0.7× | 3.2k 0.9× | 743 0.4× | 1.0k 0.6× | 37 | 6.8k |
Countries citing papers authored by Masao Honda
Since
Specialization
Citations
This map shows the geographic impact of Masao Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masao Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masao Honda more than expected).
Fields of papers citing papers by Masao Honda
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Masao Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masao Honda. The network helps show where Masao Honda may publish in the future.
Co-authorship network of co-authors of Masao Honda
This figure shows the co-authorship network connecting the top 25 collaborators of Masao Honda. A scholar is included among the top collaborators of Masao Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masao Honda. Masao Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Li, Ying-Yi, et al.. (2024). Roles Played by DOCK11, a Guanine Nucleotide Exchange Factor, in HBV Entry and Persistence in Hepatocytes. Viruses. 16(5). 745–745.
2.
Nio, Kouki, Tetsuro Shimakami, Kazuyuki Kuroki, et al.. (2023). Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors. Viruses. 15(5). 1178–1178.
3.
Takeshita, Yumie, Hiroaki Takayama, Hisanori Goto, et al.. (2023). Trajectories of Liver Fibrosis and Gene Expression Profiles in Nonalcoholic Fatty Liver Disease Associated With Diabetes. Diabetes. 72(9). 1297–1306.
4.
Inaba, Y., Hitoshi Watanabe, Kumi Kimura, et al.. (2023). The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice. Nature Communications. 14(1). 167–167.
5.
Yamashita, Taro, Taro Yamashita, Hajime Sunagozaka, et al.. (2022). Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma. International Journal of Molecular Sciences. 23(5). 2801–2801.
6.
Iida, Noriho, Eishiro Mizukoshi, Tatsuya Yamashita, et al.. (2021). Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nature Cancer. 2(10). 1039–1054.
7.
Shimizu, Yoshiaki, Kuniaki Arai, Taro Yamashita, et al.. (2020). Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Liver. Liver Cancer. 9(3). 261–274.
8.
Nasti, Alessandro, Akihiro Seki, Takuya Komura, et al.. (2020). Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis. Journal for ImmunoTherapy of Cancer. 8(2). e001367–e001367.
9.
Yamada, Kazutoshi, Eishiro Mizukoshi, Takuya Seike, et al.. (2019). Serum C16:1n7/C16:0 ratio as a diagnostic marker for non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 34(10). 1829–1835.
10.
Shirasaki, Takayoshi, Masao Honda, Tetsuro Shimakami, et al.. (2018). Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro. International Journal of Molecular Sciences. 19(2). 108–108.
11.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2015). Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib. Hepatology Research. 46(7). 650–656.
12.
Terashima, Takeshi, Tatsuya Yamashita, Noriho Iida, et al.. (2014). Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy. Hepatology Research. 45(9). 949–959.
13.
Honda, Masao, Akihiro Tanaka, Yoshimoto Nomura, et al.. (2013). Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C. Clinical Cancer Research. 19(7). 1827–1837.
14.
Komura, Takuya, Yoshio Sakai, Masao Honda, et al.. (2013). ER stress induced impaired TLR signaling and macrophage differentiation of human monocytes. Cellular Immunology. 282(1). 44–52.
15.
Okada, Hikari, Masao Honda, Jean S. Campbell, et al.. (2012). Acyclic Retinoid Targets Platelet-Derived Growth Factor Signaling in the Prevention of Hepatic Fibrosis and Hepatocellular Carcinoma Development. Cancer Research. 72(17). 4459–4471.
16.
Yamashita, Taro, Masao Honda, Kouki Nio, et al.. (2010). Oncostatin M Renders Epithelial Cell Adhesion Molecule–Positive Liver Cancer Stem Cells Sensitive to 5-Fluorouracil by Inducing Hepatocytic Differentiation. Cancer Research. 70(11). 4687–4697.
17.
Kitao, Azusa, Yasunori Sato, Seiko Sawada‐Kitamura, et al.. (2009). Endothelial to Mesenchymal Transition via Transforming Growth Factor-β1/Smad Activation Is Associated with Portal Venous Stenosis in Idiopathic Portal Hypertension. American Journal Of Pathology. 175(2). 616–626.
18.
Sakai, Yoshio, et al.. (2008). Common Transcriptional Signature of Tumor-Infiltrating Mononuclear Inflammatory Cells and Peripheral Blood Mononuclear Cells in Hepatocellular Carcinoma Patients. Cancer Research. 68(24). 10267–10279.
19.
Yamashita, Taro, Junfang Ji, Anuradha Budhu, et al.. (2008). EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features. Gastroenterology. 136(3). 1012–1024.e4.
20.
Narita, Masako, et al.. (1978). [Nonivasive detection of regional myocardial perfusion abnormality by scintigraphic technique (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(1). 57–67.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hitoshi Yoshiji Breakdown of academic impact, for papers by Steven Dooley Breakdown of academic impact, for papers by Steven F. Bronk Breakdown of academic impact, for papers by Tatsuya Yamashita Breakdown of academic impact, for papers by Matías A. Ávila Breakdown of academic impact, for papers by Norifumi Kawada Breakdown of academic impact, for papers by Claus Hellerbrand Breakdown of academic impact, for papers by Isao Sakaida Breakdown of academic impact, for papers by Tatiana Kisseleva Breakdown of academic impact, for papers by Christoph H. Österreicher